https://doi.org/10.4081/uij.2023.306

Impact of vaginal submucosal platelet-rich plasma combined with non-cross-linked hyaluronic acid injections on dyspareunia and sexual satisfaction in a Hodgkin lymphoma cancer survivor: a case report

Vol. 35 No. 1 (2023)
Submitted: 25 March 2023
Accepted: 16 May 2023
Published: 30 May 2023
platelet-rich plasma, vulvovaginal atrophy, cancer, hyaluronic acid
Abstract Views: 749
PDF: 140
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Salma Samir Omar
salma.samir@alexmed.edu.eg
https://orcid.org/0000-0001-9546-4366
Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Khaled F. Elmulla
Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Noran Abo Khadr
Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Ahmed Ashour Badawy
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Eman Nabih Ramadan
https://orcid.org/0009-0006-6931-4106
Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Ahmed Hassouna
https://orcid.org/0009-0008-6572-927X
Consultant of Gynaecology and Obstetrics, Elshatby University Hospital, Alexandria University, Alexandria, Egypt.
Lamia Heikal
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Waleed Arafat
https://orcid.org/0000-0002-6617-5992

Vaginal atrophy is a commonly encountered problem among young cancer survivors. Patients suffer from vaginal dryness, irritation, and dyspareunia secondary to oestrogen deficiency. Oestrogenbased hormone replacement therapy is effective, but unfortunately health concerns or contraindications in cancer survivors frequently limit its use. A 35-year-old female patient with dyspareunia that markedly affected her sexual relationship was referred to the gynaecology clinic. Treatment using topical oestrogen cream and sexual counselling were not successful. We treated her using two submucosal injections of PRP-non-cross-linked hyaluronic acid injections into the vestibule and lower third of the anterior vaginal wall mucosa, spaced a month apart. The patient reported marked reduction of dyspareunia and demonstrated an improvement of FSFI total score 1 month after the second injection. Both the patient and her husband showed an improvement of the index of sexual satisfaction score one month after the second injection compared to their pretreatment scores. Examination of the vaginal mucosa showed improvement of thickness and integrity of the mucosa and increased lubrication. PRP-non-cross-linked hyaluronic acid submucosal injections can be effective for cancer therapy-related vaginal atrophy, coitus-related pain, and sexual satisfaction.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Ranger TA, Burchardt J, Clift AK, et al. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper. BMJ Open 2021;11:e046701. DOI: https://doi.org/10.1136/bmjopen-2020-046701
Angelou K, Grigoriadis T, Diakosavvas M, et al. The Genitourinary syndrome of menopause: an overview of the recent data. Cureus 2020;12:e7586. DOI: https://doi.org/10.7759/cureus.7586
D'Oria O, Giannini A, Buzzaccarini G, et al. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review. Eur J Obstet Gynecol Reprod Biol 2022;277:84-9. DOI: https://doi.org/10.1016/j.ejogrb.2022.08.012
Moral E, Delgado JL, Carmona F, et al. The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women. Menopause 2018;25:1418-23. DOI: https://doi.org/10.1097/GME.0000000000001148
The NGSMPSEP. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020;27:976-92. DOI: https://doi.org/10.1097/GME.0000000000001609
Benini V, Ruffolo AF, Casiraghi A, et al. New innovations for the treatment of vulvovaginal atrophy: an up-to-date review. Medicina (Kaunas) 2022;58. DOI: https://doi.org/10.3390/medicina58060770
Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause 2018;25:596-608. DOI: https://doi.org/10.1097/GME.0000000000001121
Desai SA, Kroumpouzos G, Sadick N. Vaginal rejuvenation: From scalpel to wands. Int J Womens Dermatol 2019;5:79-84. DOI: https://doi.org/10.1016/j.ijwd.2019.02.003
Torella M, Del Deo F, Grimaldi A, et al. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2016;207:125-8. DOI: https://doi.org/10.1016/j.ejogrb.2016.10.018
Schiavi MC, Porpora MG, Vena F, et al. Orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin, and quercetin in the prevention of postcoital recurrent urinary tract infections: analysis of 98 women in reproductive age after 6 months of treatment. Female Pelvic Med Reconstr Surg 2019;25:309-12. DOI: https://doi.org/10.1097/SPV.0000000000000560
Zheng Z, Yin J, Cheng B, Huang W. Materials selection for the injection into vaginal wall for treatment of vaginal atrophy. Aesthetic Plastic Surg 2021;45:1231-41. DOI: https://doi.org/10.1007/s00266-020-02054-w
Saleh DM, Abdelghani R. Clinical evaluation of autologous platelet rich plasma injection in postmenopausal vulvovaginal atrophy: A pilot study. J Cosmetic Dermatol 2022;21:4269-75. DOI: https://doi.org/10.1111/jocd.14873
Prodromidou A, Zacharakis D, Athanasiou S, et al. The emerging role on the use of platelet-rich plasma products in the management of urogynaecological disorders. Surg Innov 2022;29:80-7. DOI: https://doi.org/10.1177/15533506211014848
Zacharakis D, Pitsouni E, Grigoriadis T, et al. Minimal invasive procedures for the treatmentof genitourinary syndrome of menopause (GSM).Un update. HjoG 2020;19:35-44. DOI: https://doi.org/10.33574/hjog.1933
Combs MR, Denomme G, Grossman BJ, et al. In: Brecher ME, Leger RM, Roseff SD, editors. AABB Technical Manual. 15th ed: American Association of Blood Banks; 2005. p. 815-7.
Anis TH, Gheit SA, Saied HS, Al kherbash SA. Arabic translation of Female Sexual Function Index and validation in an Egyptian population. J Sex Med 2011;8:3370-8. DOI: https://doi.org/10.1111/j.1743-6109.2011.02471.x
Attaky A, Schepers J, Kok G, Dewitte M. The role of sexual desire, sexual satisfaction, and relationship satisfaction in the sexual function of arab couples living in Saudi Arabia. Sex Med 2021;9:100303. DOI: https://doi.org/10.1016/j.esxm.2020.100303
Swerdlow AJ, Cooke R, Bates A, et al. Risk of premature menopause after treatment for Hodgkin's lymphoma. J Natl Cancer Inst 2014;106. DOI: https://doi.org/10.1093/jnci/dju207
Sukgen G, Ellibes Kaya A, Karagun E, Caliskan E. Platelet-rich plasma administration to the lower anterior vaginal wall to improve female sexuality satisfaction. Turk J Obstet Gynecol 2019;16:228-34. DOI: https://doi.org/10.4274/tjod.galenos.2019.23356
Hersant B, SidAhmed-Mezi M, Belkacemi Y, et al. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause 2018;25:1124-30. DOI: https://doi.org/10.1097/GME.0000000000001122
Khaled F. Elmulla, Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria

 

 

Noran Abo Khadr, Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria

 

 

Ahmed Ashour Badawy, Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Alexandria

 

 

Eman Nabih Ramadan, Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria

 

 

Ahmed Hassouna, Consultant of Gynaecology and Obstetrics, Elshatby University Hospital, Alexandria University, Alexandria

 

 

Lamia Heikal, Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria

 

 

Waleed Arafat

 

 

How to Cite

Omar, S. S., Elmulla, K. F., Abo Khadr, N., Ashour Badawy, A., Nabih Ramadan, E., Hassouna, A., … Arafat, W. (2023). Impact of vaginal submucosal platelet-rich plasma combined with non-cross-linked hyaluronic acid injections on dyspareunia and sexual satisfaction in a Hodgkin lymphoma cancer survivor: a case report. Urogynaecologia, 35(1). https://doi.org/10.4081/uij.2023.306
Copyright (c) 2023 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.